Globus Medical, Inc. (GMED)
NYSE: GMED · IEX Real-Time Price · USD
50.43
+0.64 (1.29%)
May 1, 2024, 4:00 PM EDT - Market closed
Globus Medical Revenue
In the year 2023, Globus Medical had annual revenue of $1.57B with 53.34% growth. Revenue in the quarter ending December 31, 2023 was $616.53M with 124.60% year-over-year growth.
Revenue (ttm)
$1.57B
Revenue Growth
+53.34%
P/S Ratio
4.35
Revenue / Employee
$313,695
Employees
5,000
Market Cap
6.83B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.57B | 545.63M | 53.34% |
Dec 31, 2022 | 1.02B | 64.74M | 6.76% |
Dec 31, 2021 | 958.10M | 169.06M | 21.43% |
Dec 31, 2020 | 789.04M | 3.67M | 0.47% |
Dec 31, 2019 | 785.37M | 72.40M | 10.15% |
Dec 31, 2018 | 712.97M | 76.99M | 12.11% |
Dec 31, 2017 | 635.98M | 71.98M | 12.76% |
Dec 31, 2016 | 563.99M | 19.24M | 3.53% |
Dec 31, 2015 | 544.75M | 70.38M | 14.84% |
Dec 31, 2014 | 474.37M | 39.91M | 9.19% |
Dec 31, 2013 | 434.46M | 48.47M | 12.56% |
Dec 31, 2012 | 385.99M | 54.52M | 16.45% |
Dec 31, 2011 | 331.48M | 43.28M | 15.02% |
Dec 31, 2010 | 288.20M | 33.85M | 13.31% |
Dec 31, 2009 | 254.34M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Elanco Animal Health | 4.42B |
DENTSPLY SIRONA | 3.97B |
Jazz Pharmaceuticals | 3.83B |
The Ensign Group | 3.73B |
Acadia Healthcare Company | 2.93B |
Exelixis | 1.83B |
HealthEquity | 999.59M |
Intra-Cellular Therapies | 464.37M |
GMED News
- 15 days ago - Globus Medical Schedules First Quarter Earnings Release and Conference Call - GlobeNewsWire
- 2 months ago - Globus Medical Reports Fourth Quarter and Full Year 2023 Results - GlobeNewsWire
- 2 months ago - Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call - GlobeNewsWire
- 3 months ago - Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer - GlobeNewsWire
- 4 months ago - Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results - GlobeNewsWire
- 6 months ago - Globus Medical Reports Third Quarter 2023 Results - GlobeNewsWire
- 6 months ago - Globus Medical Schedules Third Quarter Earnings Release and Conference Call - GlobeNewsWire
- 6 months ago - Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting - GlobeNewsWire